MEI Pharma, Inc. (MEIP)

MEI Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Net Income	-31.84	-54.45	-41.31	-47.17	-16.82
Depreciation & Amortization	1.82	1.24	0.29	0.11	0.08
Share-Based Compensation	3.59	8.35	10.25	6.8	6.56
Other Operating Activities	-26.05	-3.88	-1.18	74.52	-19.25
Operating Cash Flow	-52.48	-48.75	-31.96	34.26	-29.42
Capital Expenditures	-0.04	-0.48	-0.71	-0.89	-0.22
Change in Investments	53.73	7.37	25.42	-105.4	24.54
Investing Cash Flow	53.69	6.89	24.71	-106.29	24.32
Share Issuance / Repurchase	0	52.9	3.53	78.51	1.71
Other Financing Activities	-0.04	-3.85	-0.06	-3.73	-0.32
Financing Cash Flow	-0.04	49.05	3.47	74.78	1.39
Net Cash Flow	1.17	7.2	-3.79	2.74	-3.72
Free Cash Flow	-52.52	-49.23	-32.67	33.36	-29.64
Free Cash Flow Margin	-107.59%	-120.95%	-93.90%	120.20%	-603.05%
Free Cash Flow Per Share	-7.88	-7.91	-5.81	7.33	-8.33

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).